No Data
Express News | GeneDx Holdings Corp : TD Cowen Raises Target Price to $46 From $24
13D Filings -- Barron's
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
All You Need to Know About GENEDX HOLDINGS (WGS) Rating Upgrade to Strong Buy
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results
GeneDx Holdings Initiated at Buy by Craig-Hallum
GeneDx Holdings Initiated at Buy by Craig-
GeneDx Holdings Price Target Announced at $43.00/Share by Craig-Hallum
GeneDx Holdings Price Target Announced at $43.00/Share by Craig-
Mars MoooOP :